tetano
Editor, Senior Moderator
Influenza Other Respir Viruses
. 2025 Mar;19(3):e70091.
doi: 10.1111/irv.70091. The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration
Marta C Nunes[SUP] 1 [/SUP], Cecile Chauvel[SUP] 1 [/SUP], Sonia M Raboni[SUP] 2 [/SUP], F Xavier López-Labrador[SUP] 3 [/SUP], Melissa K Andrew[SUP] 4 [/SUP], Nazish Badar[SUP] 5 [/SUP], Vicky Baillie[SUP] 6 [/SUP], Antonin Bal[SUP] 7 [/SUP], Kedar Baral[SUP] 8 [/SUP], Elsa Baumeister[SUP] 9 [/SUP], Celina Boutros[SUP] 10 [/SUP], Elena Burtseva[SUP] 11 [/SUP], Daouda Coulibaly[SUP] 12 [/SUP], Ben Cowling[SUP] 13 [/SUP], Daria Danilenko[SUP] 14 [/SUP], Ghassan Dbaibo[SUP] 10 [/SUP], Gregory Destras[SUP] 7 [/SUP], Ndongo Dia[SUP] 15 [/SUP], Anca Cristina Drăgănescu[SUP] 16 [/SUP], Heloisa I G Giamberardino[SUP] 17 [/SUP], Doris Gomez-Camargo[SUP] 18 [/SUP], Laurence Josset[SUP] 7 [/SUP], Parvaiz A Koul[SUP] 19 [/SUP], Jan Kyncl[SUP] 20 [/SUP], Victor Alberto Laguna-Torres[SUP] 21 [/SUP], Odile Launay[SUP] 22 [/SUP], Liem Binh Luong Nugyen[SUP] 23 [/SUP], Shelly McNeil[SUP] 24 [/SUP], Snežana Medić[SUP] 25 [/SUP], Ainara Mira-Iglesias[SUP] 3 [/SUP], Alla Mironenko[SUP] 26 [/SUP], Aneta Nitsch-Osuch[SUP] 27 [/SUP], Alejandro Orrico-Sánchez[SUP] 3 [/SUP], Nancy A Otieno[SUP] 28 [/SUP], Hadrien Regue[SUP] 29 [/SUP], Guillermo M Ruiz-Palacios[SUP] 30 [/SUP], Afif Ben Salah[SUP] 31 [/SUP], Muhammad Salman[SUP] 5 [/SUP], Oana Săndulescu[SUP] 32 [/SUP], Viviana Simon[SUP] 33 [/SUP], Anna Sominina[SUP] 14 [/SUP], Emilia Sordillo[SUP] 33 [/SUP], Mine Durusu Tanriover[SUP] 34 [/SUP], Serhat Unal[SUP] 35 [/SUP], Harm van Bakel[SUP] 33 [/SUP], Philippe Vanhems[SUP] 36 [/SUP], Tao Zhang[SUP] 37 [/SUP], Catherine Commaille-Chapus[SUP] 38 [/SUP], Camille Hunsinger[SUP] 38 [/SUP], Joseph Bresee[SUP] 39 [/SUP], Bruno Lina[SUP] 7 [/SUP], John W McCauley[SUP] 40 [/SUP], Justin R Ortiz[SUP] 41 [/SUP], Cecile Viboud[SUP] 42 [/SUP], Wenqing Zhang[SUP] 43 [/SUP], Laurence Torcel-Pagnon[SUP] 44 [/SUP], Cedric Mahe[SUP] 44 [/SUP], Sandra S Chaves[SUP] 44 [/SUP]
Affiliations
Respiratory viruses represent a significant public health threat. There is the need for robust and coordinated surveillance to guide global health responses. Established in 2012, the Global Influenza Hospital Surveillance Network (GIHSN) addresses this need by collecting clinical and virological data on persons with acute respiratory illnesses across a network of hospitals worldwide. GIHSN utilizes a standardized patient enrolment and data collection protocol across its study sites. It leverages pre-existing national infrastructures and expert collaborations to facilitate comprehensive data collection. This includes demographic, clinical, epidemiological, and virologic data, and whole genome sequencing (WGS) for a subset of viruses. Sequencing data are shared in the Global Initiative on Sharing All Influenza Data (GISAID). GIHSN uses financing and governance approaches centered around public-private partnerships. Over time, GIHSN has included more than 100 hospitals across 27 countries and enrolled more than 168,000 hospitalized patients, identifying 27,562 cases of influenza and 44,629 of other respiratory viruses. GIHSN has expanded beyond influenza to include other respiratory viruses, particularly since the COVID-19 pandemic. In November 2023, GIHSN strengthened its global impact through a memorandum of understanding with the World Health Organization, aimed at enhancing collaborative efforts and data sharing for improved health responses. GIHSN exemplifies the value of integrating scientific research with public health initiatives through global collaboration and public-private partnerships governance. Future efforts should enhance the scalability of such models and ensure their sustainability through continued public and private support.
Keywords: influenza; international; public–private partnerships; respiratory viruses; surveillance.
. 2025 Mar;19(3):e70091.
doi: 10.1111/irv.70091. The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration
Marta C Nunes[SUP] 1 [/SUP], Cecile Chauvel[SUP] 1 [/SUP], Sonia M Raboni[SUP] 2 [/SUP], F Xavier López-Labrador[SUP] 3 [/SUP], Melissa K Andrew[SUP] 4 [/SUP], Nazish Badar[SUP] 5 [/SUP], Vicky Baillie[SUP] 6 [/SUP], Antonin Bal[SUP] 7 [/SUP], Kedar Baral[SUP] 8 [/SUP], Elsa Baumeister[SUP] 9 [/SUP], Celina Boutros[SUP] 10 [/SUP], Elena Burtseva[SUP] 11 [/SUP], Daouda Coulibaly[SUP] 12 [/SUP], Ben Cowling[SUP] 13 [/SUP], Daria Danilenko[SUP] 14 [/SUP], Ghassan Dbaibo[SUP] 10 [/SUP], Gregory Destras[SUP] 7 [/SUP], Ndongo Dia[SUP] 15 [/SUP], Anca Cristina Drăgănescu[SUP] 16 [/SUP], Heloisa I G Giamberardino[SUP] 17 [/SUP], Doris Gomez-Camargo[SUP] 18 [/SUP], Laurence Josset[SUP] 7 [/SUP], Parvaiz A Koul[SUP] 19 [/SUP], Jan Kyncl[SUP] 20 [/SUP], Victor Alberto Laguna-Torres[SUP] 21 [/SUP], Odile Launay[SUP] 22 [/SUP], Liem Binh Luong Nugyen[SUP] 23 [/SUP], Shelly McNeil[SUP] 24 [/SUP], Snežana Medić[SUP] 25 [/SUP], Ainara Mira-Iglesias[SUP] 3 [/SUP], Alla Mironenko[SUP] 26 [/SUP], Aneta Nitsch-Osuch[SUP] 27 [/SUP], Alejandro Orrico-Sánchez[SUP] 3 [/SUP], Nancy A Otieno[SUP] 28 [/SUP], Hadrien Regue[SUP] 29 [/SUP], Guillermo M Ruiz-Palacios[SUP] 30 [/SUP], Afif Ben Salah[SUP] 31 [/SUP], Muhammad Salman[SUP] 5 [/SUP], Oana Săndulescu[SUP] 32 [/SUP], Viviana Simon[SUP] 33 [/SUP], Anna Sominina[SUP] 14 [/SUP], Emilia Sordillo[SUP] 33 [/SUP], Mine Durusu Tanriover[SUP] 34 [/SUP], Serhat Unal[SUP] 35 [/SUP], Harm van Bakel[SUP] 33 [/SUP], Philippe Vanhems[SUP] 36 [/SUP], Tao Zhang[SUP] 37 [/SUP], Catherine Commaille-Chapus[SUP] 38 [/SUP], Camille Hunsinger[SUP] 38 [/SUP], Joseph Bresee[SUP] 39 [/SUP], Bruno Lina[SUP] 7 [/SUP], John W McCauley[SUP] 40 [/SUP], Justin R Ortiz[SUP] 41 [/SUP], Cecile Viboud[SUP] 42 [/SUP], Wenqing Zhang[SUP] 43 [/SUP], Laurence Torcel-Pagnon[SUP] 44 [/SUP], Cedric Mahe[SUP] 44 [/SUP], Sandra S Chaves[SUP] 44 [/SUP]
Affiliations
- PMID: 40082217
- DOI: 10.1111/irv.70091
Respiratory viruses represent a significant public health threat. There is the need for robust and coordinated surveillance to guide global health responses. Established in 2012, the Global Influenza Hospital Surveillance Network (GIHSN) addresses this need by collecting clinical and virological data on persons with acute respiratory illnesses across a network of hospitals worldwide. GIHSN utilizes a standardized patient enrolment and data collection protocol across its study sites. It leverages pre-existing national infrastructures and expert collaborations to facilitate comprehensive data collection. This includes demographic, clinical, epidemiological, and virologic data, and whole genome sequencing (WGS) for a subset of viruses. Sequencing data are shared in the Global Initiative on Sharing All Influenza Data (GISAID). GIHSN uses financing and governance approaches centered around public-private partnerships. Over time, GIHSN has included more than 100 hospitals across 27 countries and enrolled more than 168,000 hospitalized patients, identifying 27,562 cases of influenza and 44,629 of other respiratory viruses. GIHSN has expanded beyond influenza to include other respiratory viruses, particularly since the COVID-19 pandemic. In November 2023, GIHSN strengthened its global impact through a memorandum of understanding with the World Health Organization, aimed at enhancing collaborative efforts and data sharing for improved health responses. GIHSN exemplifies the value of integrating scientific research with public health initiatives through global collaboration and public-private partnerships governance. Future efforts should enhance the scalability of such models and ensure their sustainability through continued public and private support.
Keywords: influenza; international; public–private partnerships; respiratory viruses; surveillance.